24
Pula J.H., MacDonald C.J. Current options for the treatment of optic neuritis // Clin.
Opthalmol.
–
2012.
–
№ 6. –
P. 1211-1223.
Rabie M., Nevo Y.
Childhood acute and chronic immune-mediated
polyradiculoneuropathies // Eur. J. Paediatr. Neurol.
–
2009.
–
Vol. 13, № 3. –
P. 209-
218.
Rafael G.C., Chevret S. Rational therapy of Guillain-
Barré syndrome // Lancet.
-
1998. -
Vol. 351, № 9104.
-P. 753.
Ramunni A., De Robertis F., Brescia P. et al. A case report of double filtration
plasmapheresis in an acute episode of multiple sclerosis // Ther. Apher. Dial.
–
2008.
–
Vol. 12, № 3. –
P. 250-254.
Ric G.P.A., Paszner B., Oger J. et al. The evolution of neutralizing antibodies in
multiple sclerosis patients treated with interferon
-1b // Neurology.
–
1999.
–
Vol. 52,
№ 6. –
P. 1277-1279.
Riemer C., G
ü
ltner S., Heise I. et al. Neuroinflammation in prion diseases: concepts
and targets for therapeutic intervention // 2009.
–
Vol. 8, № 5. –
P. 329-341.
Rogalewski A., Kraus J., Hasselblatt M. et al. Improvement of advanced
postvaccinal demyelinating encephalitis due to plasmapheresis // Neuropsychiatr. Dis.
Treat.
–
2007.
–
Vol. 3, № 6. –
P. 987-991.
Sanders D.B. Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-
mediates mechanisms, and update on therapies // Ann. Neurol. - 1995. - Vol. 37, Suppl.
1. - P. S63-S73.
Sanford M., Lyseng-Williamson K.A. Subcutaneous recombinant interferon-
β
-1a
(Rebif): a review of its use in the treatment of relapsing multiple sclerosis // Drugs.
–
2011.
–
Vol. 71, № 14. –
P. 1865-1891.
Saiz A., Arpa J., Sagasta A. et al. Autoantibodies to glutamic acid decarboxylase in
three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and
polyendocrine autoimmunity // Neurology. - 1997. -
Vol. 49, № 4.
- P. - 1026-1030.
Schimmel M., Bien C.G., Vincent A. et al. Successful treatment of anti-N-methyl-D-
aspartate receptor encephalitis presenting with catatonia // Arch. Dis. Child.
–
2009.
–
Vol. 94, № 4. –
P 314-316.
Schr
ö
der A., Linker R.A., Gold R. // Plasmapheresis for neurologic disorders.
–
2009.
–
Vol. 9, № 9. –
P. 1331-1339.
Sevy A., Doche E., Squarcioni C. et al. Stroke in a young patient treated by
alteplase heralding an acquired thrombotic thrombocytopenic purpura // J. Clin. Apher.
–
2011.
–
Vol. 26, № 3. –
P. 152-155.
Shariatmadar S., Noto T.A. Plasma exchange in stiff-man syndrome // Ther. Apher.
–
2001.
–
Vol. 5, № 1. –
P. 74-67.
Shinozaki K., Oda S., Sadahiro T. et al. A case report of plasmapheresis in the
treatment of acute disseminated encephalomyelitis // Ther. Apher. Dial.
–
2008.
–
Vol.
12, № 5. –
P. 401-405.
25
Sinha S., Newsom-Devis J., Mills K. et al. Autoimmune aetiology for acquired
neu
romyotonia (Isaacs’ syndrome) // Lancet.
- 1991. -
Vol. 338, № 8758.
- P. 75-77.
Smith R.G., Siklos L., Alexianu M.E. et al. Autoimmunity and ALS // Neurology. -
1996. -
Vol. 47, № 4, Suppl. 2.
- P. S40-S46.
Sorensen P.S. Neutralizing antibodies against interferon-beta // Ther. Adv. Neurol.
Disord.
–
2008. 0 Vol. 1, № 2. –
P. 62-78.
Soria A., Maubec E., Henry-Feugeas M.C. et al. [Panniculitis induced by interferon
beta-a] // Ann. Dermatol. Venerol.
–
2007.
–
Vol. 134, № 4 Pt 1. –
P. 374-377.
Sriram S., Rodrigues M. Indictment of the microglia as the villain in multiple
sclerosis // Neurology. - 1997. -
Vol. 48, № 2.
- P. 464-470.
Staines D.R. Postulated vasoactive neurupeptide autoimmunity in fatigue-related
conditions: a brief review and hypothesis // Clin. Dev. Imunol.
–
2006.
–
Vol. 13, № 1. –
P. 25-39.
Staines D.R.
Is Parkinson’s disease an autoimmune disorder of endogenous
vasoactive neuropeptides? // Med. Hypotheses.
–
2007.
–
Vol. 69, № 6. –
P. 1208-
1211.
Straub J., Chofflon M., Delavelle J. Early high-dose intravenous methylprednisolone
in acute disseminated encephalomyelitis: A successful recovery // Neurology. - 1997. -
Vol. 49, № 4.
- P. 1145-1147.
Tan I.L., McArthur J.C., Clifford D.B. et al. Immune reconstitution inflammatory
syndrome in natalizumab-associated PML // Neurology.
–
2011.
–
Vol. 77, № 11. –
P.
1061-1067.
Tanne D., D’Olhaberriague L., Schultz L.R. et al.
Anticardiolipin antibodies and their
associations with cerebrovascular risk factors // Neurology.
–
1999.
–
Vol. 52, № 7. –
P.
1368-1373.
Tharakan J., Jayapraksh P.A., Iyer V.P. Small volume plasma exchange in Guillain-
Barre syndrome: experience in 25 patients // J. Assoc. Physicians India.
–
1990.
–
Vol.
38, № 8. –
P. 550-553.
The French Cooperative Group on Plasma Exchange in Guillain-
Barré Syndrome.
Appropriate number of plasma exchanges in Guillain-
Barré Syndrome // Ann.
Neurol. -
1997. -
Vol. 41, № 3.
- P. 299-306.
Tietjen G.E., Day M., Norris L. et al. Role of anticardiolipin antibodies in young
persons with migraine and transient focal neurologic events // Neurology. - 1998. - Vol.
50, № 5
. - P. 1433-1440.
Tranchant C. Therapeutic strategy in myasthenia gravis // Rev. Neurol. (Paris).
–
2009.
–
V0l. 165, № 2. –
P. 149-154.
Trebst C., Reising A., Kielstein J.T. et al. Plasma exchange therapy in steroid-
unresponsive relapses in patients with multiple sclerosis // Blood Purif.
–
2009.
–
V0l.
28, № 2. –
P. 108-115.
26
Tuomi T., Björses P., Falorni A. et al.
Antibodies to glutamic acid decarboxilase and
insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome typ I //
J. Clin. Endocrin. Metab. - 1999. -
Vol. 81, № 4.
- P. 1488-1494.
Ueda T., Kanda F., Kobessho H. et al.
“Droped head syndrome” caused by
Lambert-Eaton myasthenic syndrome // Muscle Nerve.
–
2009.
–
Vol. 40, № 1. –
P.
134-136.
Valbonesi M., Bo A., De Luidgi M.C. et al. Cascade filtration (CF) with the
Haemonetics MCS+: a new technical adaptation // Int. J. Artif. Organs.
–
2001.
–
Vol.
24, № 3. –
P. 164-166.
Van Boxel-Dezaire A.H.H., Hoff S.C.J., van Oosten B.W. et al. Decreased
interleukin-10 and increased interleukin-12p40 mPNA are associated with disease
activity and characterize different discase stages in miltiple sclerosis // Ann. Neurol.
–
1999.
–
Vol. 45, № 6. –
P. 695-703.
Wanders R.J.A., Waterham H.R., Leroy B.P. Refsum disease / In: Pagon R.A.
editors. GeneReviews [Internet}. Seattle (WA): University of Washington, Seattle; 1993-
2006 [updated 2010- Apr. 22].
Wang K.C., Wang S.J., Lee C.L. et al. The rescue effect of plasma exchange for
neuromyelitis optica // J. Clin. Neurosci.
–
2011.
–
Vol. 18, № 1. –
43-46.
Watanabe S., Nakashima I., Misu T. et al. Therapeutic efficacy of plasma exchange
in NMO-IgG-positive patients with neuromyelitis optica // Mult. Scler.
–
2007.
–
Vol. 13,
№ 1. –
P. 128-132.
Weinshenker B.G. Plasma exchange for acute attacks of demyelinating disease:
detecting a Lazarus effect // Ther. Apher.
–
2000.
–
Vol 4, № 3. –
P. 187-189.
Winters J.L., Brown D., Hazard E. et al. Cost-minimization analysis of the direct
costs of TPE and IVIg in the treatment of Guillain-Barr
é
syndrome // BMC Health. Serv.
Res.
–
2011.
–
№ 11. –
P. 101.
Yeh J.H., Chiu H.C. Comparison between double-filtration plasmapheresis and
immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis //
J. Neurol.
–
2000.
–
Vol. 247, № 7. –
P. 510-513.
Yeh J.H., Chen W.H., Chiu H.C. Double filtration plasmapheresis in the treatment of
myasthenic crisis
–
analysis of prognostic factors and efficacy // Acta Neurol. Scand.
–
2001.
–
Vol. 104, № 2. –
P. 78-82.
Yeh J.H., Chen W.H., Chiu H.C. Predicting the course of myasthenic weakness
following double failtration plasmapheresis // Acta Neurol. Scand.
–
2003.
–
Vol. 108, №
3.
–
P. 174-178.
Yeh J.H., Chen W.H., Huang K.M., Chiu H.C. Prethymectomy plasmapheresis in
myasthenia gravis // J. Clin. Apher.
–
2005. -
Vol. 20, № 4. –
P. 217-221.
Yoshida H., Ando A., Sho K. et al. Anti-aquaporin-4 antibody-positive optic neuritis
with double-filtration plasmapheresis // J. Ocul. Pharmacol. Ther.
–
2010.
–
Vol. 26, №
4.
–
P. 381-385.
27
Y
ü
cesan C., Arslan O., Arat M. et al. Therapeutic plasma exchange in the treatment
of neuroimmunologic disorders: review of 50 cases // Transfus. Apher. Sci.
–
2008. Vol.
36, № 1. –
P. 103-107.
Yuki N., Tagawa Y., Handa S. Autoantibodies to peripheral nerve glycosphingolipids
SPG, SLPG, and SGPG in Guillain-
Barré syndrome and chronic inflammatory
demyelinating polyneuropathy // J. Neuroimmunol. - 1996. -
V. 70, № 1.
- P. 1-6.
Yuki N., Koda M., Hirata K. Isolated internal ophthalmoplegia associated with
immunoglobulin G anti-GQ1b antibody // Neurology.
–
1998.
–
Vol. 51, № 5. –
P. 1515-
1516.
Yuki N. Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff
syndrome) // J. Neuroimmunol.
–
2009.
–
Vol. 215, № 1
-2.
–
P. 1-9.
Zarkou S., Carter J.L., Wellik K.E. et al. Are corticosteroids efficacious for
preventing or treating neutralizing antibodies in multiple sclerosis patients treated with
beta-interferons? A critically appraised topic // Neurologist.
–
2010.
–
Vol. 16, № 3. –
P.
212-214.
Zisimopoulou P., Lagoumintzis G., Kostelidou K. et al. Towards antigen-specific
apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia
gravis by plasmapheresis // J. Neuroimmunol.
–
2008.
–
Vol. 15, 201-202.
–
P. 95-103.
Russian literature
Barbas I.M., Skoromets
А
.
А
. [Multiple Sclerosis. Experience in the treatment and
prevetion of exacerbations].
–
Saint-Petersburg.: SOTIS, 2003.
–
123 p.
Voinov V.A. [Efferent therapy. Membrane plasmapheresis].
–
М
., 2010.
–
400 p.
Vostrikova I.L., Kimova M.V., Ponomarenko H.A. et al. [Specificity of antibody
mediated proteolysis of myelin basic protein in multiple sclerosis: pathogenetic and
clinical aspects] // Allergology Immunology.
–
2006.
–
Vol
. 7, № 3. –
P. 414.
Evdokimov A.V., Gerasimov M.M. [Clinico-immunological comparison at the end of
cerebral insult ] // Allergology Immunology.
–
2006.
–
Vol
. 7, № 3. –
P. 419-420.
Elchaninov A.P., Gendel L.L., Belenky L.M. et al. [Efferent therapy for complex
treating of patients during acute period of ischemic insult in association with lupus
anticoagulant (primary antiphospholipid syndrome)] // Efferent Therapy.
–
2003.
–
Vol.9,
№ 1. –
P. 80-81.
Elchaninov A.P., Gendel L.L., Belenky L.M. [Efferent therapy for complex treating of
patients with distsirkulation encephalopathy associated with lupus anticoagulant
(primary antiphospholipid syndrome)] // Efferent Therapy.
–
2003.
–
Vol
. 9, № 1. –
P.
81-82.
Kosachev V.D., Yulev N.M., Bechik S.L. [Plasma exchange for complex treating of
myasthenia] // Efferent Therapy.
–
2006.
–
Vol. 12,
№
2.
–
P. 28-31.
28
Marchuk A.I., Bulanova N.M. [Cupping of migraine attacks with the help of medical
plasmapheresis] // Proc. IX Confer. Moscow hemapheresis society. - Moscow., 1999. -
P. 32.
Orlova Yu.Yu. [Immunological and biochemical parallels of various types course of
multiple sclerosis]:
Author’s abstract magister dissertation
. - Novosibirsk, 1999. - 22 p.
Popova L.M. [Amyotrophic lateral sclerosis in prolonged life]. - Moscow: Medicine,
1998. - 143 p.
Fomina L.A., Gerasimova M.M. [Clinico-immunological analysis on distsirkulyation in
vertebro-basilar system] // Allergology Immunology.
–
2006.
–
Vol
. 7, № 3. –
P. 420.
Cherny V.I., Shramenko E.K., Logvinenko L.V. et al. [Plasmapheresis for complex
treating of demyelinating nervous diseases] //
Медико
-
соц
i
альн
i
проблеми
с
i
м’ï. –
2004.
–
Vol
. 9, № 2. –
P. 29-33.
Shapoval A.N. [Tick-born encephalitis].
–
Moscow: Medicine, 1980. - 252 p.
Dostları ilə paylaş: |